Evaluation of the effect of omega3 on pruritus in patients under peritoneal dialysis
Phase 2
- Conditions
- Pruritus in peritoneal Patients.End-stage renal disease
- Registration Number
- IRCT138808202370N5
- Lead Sponsor
- Vice Chancellor for Research, School of Medicine, Isfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Being under maintenance dialysis for at least one month; Not being under other drug treatment for pruritus; Having pruritus for at least 8 wk; No sensitivity to omega3; Volunteer to participate. Exclusion criteria: Non compliance with drug; Renal transplantation before end of therapy; anemia (Hb<7); Hyperparathyroidism (parathormone >300 eq/ml or phosphorus >7mg/dl); PT & INR rising.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decrease in Pruritus Score. Timepoint: every 2 week. Method of measurement: visual Analog scale.
- Secondary Outcome Measures
Name Time Method Coagulopathy. Timepoint: every month. Method of measurement: PT and INR.